Items where Author is "Ailinca-Luchian, S."
![]() | Up a level |
Conference or Workshop Item
Locatelli, F. and Ailinca-Luchian, S. and Bobruff, Y. and Cappellini, M. Domenica and Corbacioglu, Selim and Domm, J. and Foell, J. and De la Fuente, J. and Handgretinger, R. and Ho, T. W. and Hobbs, W. and Kattamis, A. and Li, A. and Lu, Y. and Palomino, L. and Shanbhag, N. and Sharma, A. and Sheth, S. and Sripakdeevong, P. and Wall, D. and Frangoul, H. (2021) CTX001 FOR TRANSFUSION-DEPENDENT -THALASSEMIA (TDT): SAFETY AND EFFICACY RESULTS FROM THE ONGOING CLIMB THAL-111 STUDY OF AUTOLOGOUS CRISPR-CAS9-MODIFIED CD34+HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCS). In: 48th Congress of the Italian Society of Hematology, 24 - 27 October 2021, Milano, Italy.
Corbacioglu, Selim and Locatelli, F. and Ailinca-Luchian, S. and Bobruff, Y. and Cappellini, M. D. and Domm, J. and Foell, J. and de la Fuente, J. and Handgretinger, R. and Ho, T. W. and Hobbs, W. and Kattamis, A. and Li, A. and Lu, Y. and Palomino, L. and Shanbhag, N. and Sharma, A. and Sheth, S. and Sripakdeevong, P. and Wall, D. and Frangoul, H. (2021) CTX001 for transfusion-dependent beta-thalassemia (TDT): safety and efficacy results from the ongoing CLIMB THAL-111 study of autologous CRISPR-CAS9-modified CD34(+) hematopoietic stem and progenitor cells (HSPCs). In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.

